Skip to main content
logo
Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
49.47
+2.12 (4.48%)
Jul 30, 2026, 4:00 PM EDT - Market closed

Structure Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3,51614,7804,6611,892--
Market Cap Growth
234.48%217.12%146.41%---
Enterprise Value
2,06313,3413,7811,43000
Last Close Price
49.4769.5527.1240.76--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.439.755.394.18--
P/TBV Ratio
7.448.154.959.92--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.0100.00
Net Debt / Equity Ratio
-1.00-0.95-1.02-1.020.791.65
Net Debt / EBITDA Ratio
6.988.225.594.511.722.84
Net Debt / FCF Ratio
9.126.387.465.66-3.20
Quick Ratio
25.6024.4324.5318.896.9812.39
Current Ratio
26.1624.8124.7419.147.1612.62
Return on Equity (ROE)
-11.41%-11.86%-18.60%-33.33%-54.87%-55.24%
Return on Assets (ROA)
-13.51%-14.15%-22.79%-35.35%-50.28%-50.00%
Return on Invested Capital (ROIC)
-587.98%-568.80%----
Return on Capital Employed (ROCE)
-14.11%-14.79%-23.89%-37.92%-56.12%-54.57%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-13.80%-12.46%-43.31%-3040.44%-29.31%25.08%
Total Shareholder Return
-13.80%-12.46%-43.31%-3040.44%-29.31%25.08%
SEC Filings: 10-K · 10-Q